Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review

Date: July 30, 2013
Pages: 45
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L45F2337283EN
Leaflet:

Download PDF Leaflet

Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review
Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Lorus Therapeutics Inc. (Lorus), formerly known as Imutec Pharma Inc., is a life sciences company. It focuses on the discovery, research and development of anticancer therapies.

Lorus Therapeutics Inc. Key Recent Developments

Jul 15, 2013: Lorus Therapeutics Reports Results for Fiscal Year 2013
Jun 26, 2013: Lorus Therapeutics Appoints Dr. Brad Thompson To The Board Of Directors
Apr 12, 2013: Lorus Therapeutics Reports Q3 Fiscal 2013 Results
Jan 14, 2013: Lorus Therapeutics Reports Q2 Fiscal 2013 Results
Oct 15, 2012: Lorus Therapeutics Reports Q1 Fiscal 2013 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Lorus Therapeutics Inc. - Key Facts
Lorus Therapeutics Inc. - Key Employees
Lorus Therapeutics Inc. - Key Employee Biographies
Lorus Therapeutics Inc. - Major Products and Services
Lorus Therapeutics Inc. - Pharmaceutical Pipeline Products Data
Lorus Therapeutics Inc., Pipeline Products by Therapy Area
Lorus Therapeutics Inc., Pipeline Products by Development Phase
Lorus Therapeutics Inc. - History
Lorus Therapeutics Inc. - Company Statement
Lorus Therapeutics Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Lorus Therapeutics Inc. - Business Description
Lorus Therapeutics Inc. - Corporate Strategy
Lorus Therapeutics Inc. - SWOT Analysis
SWOT Analysis - Overview
Lorus Therapeutics Inc. - Strengths
Strength - Research and Development
Strength - Product Pipeline
Strength - Strategic Alliances
Lorus Therapeutics Inc. - Weaknesses
Weakness - Manufacturing Capabilities
Lorus Therapeutics Inc. - Opportunities
Opportunity - Growing Prostate Cancer Market
Opportunity - Demographic Trends
Opportunity - Orphan Drug Designation
Lorus Therapeutics Inc. - Threats
Threat - Intense Competition
Threat - Uncertainties in R&D
Threat - Stringent Government Regulations
Lorus Therapeutics Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Lorus Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Lorus Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Lorus Therapeutics Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Lorus Therapeutics Inc., Recent Developments
Jul 15, 2013: Lorus Therapeutics Reports Results for Fiscal Year 2013
Jun 26, 2013: Lorus Therapeutics Appoints Dr. Brad Thompson To The Board Of Directors
Apr 12, 2013: Lorus Therapeutics Reports Q3 Fiscal 2013 Results
Jan 14, 2013: Lorus Therapeutics Reports Q2 Fiscal 2013 Results
Oct 15, 2012: Lorus Therapeutics Reports Q1 Fiscal 2013 Results
Aug 08, 2012: Lorus Therapeutics Reports Fiscal 2012 Results
Apr 12, 2012: Lorus Therapeutics Reports Q3 Fiscal 2012 Results
Jan 13, 2012: Lorus Therapeutics Reports Q2 Fiscal 2012 Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Lorus Therapeutics Inc., Key Facts
Lorus Therapeutics Inc., Key Employees
Lorus Therapeutics Inc., Key Employee Biographies
Lorus Therapeutics Inc., Major Products and Services
Lorus Therapeutics Inc., Number of Pipeline Products by Therapy Area
Lorus Therapeutics Inc., Number of Pipeline Products by Development Stage
Lorus Therapeutics Inc., Pipeline Products By Therapy Area and Development Phase
Lorus Therapeutics Inc., History
Lorus Therapeutics Inc., Subsidiaries
Lorus Therapeutics Inc., Key Competitors
Lorus Therapeutics Inc., Ratios based on current share price
Lorus Therapeutics Inc., Annual Ratios
Lorus Therapeutics Inc., Interim Ratios
Lorus Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Lorus Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Lorus Therapeutics Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Lorus Therapeutics Inc., Pipeline Products by Therapy Area
Lorus Therapeutics Inc., Pipeline Products by Development Phase
Lorus Therapeutics Inc., Performance Chart (2008 - 2012)
Lorus Therapeutics Inc., Ratio Charts
Lorus Therapeutics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Lorus Therapeutics Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Ask Your Question

Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: